Notes in 1 Staph Aureus

To Subscribe, use this Key

Status	Last Update	Fields
Published	02/10/2024	{{c1::Staphylococci}} are gram-positive cocci that form grape-like clusters
Published	02/10/2024	The most frequent site of Staph aureus colonisation are the {{c1::anterior nares}}
Published	02/10/2024	Infections associated with Staph. aureus {{c1::Skin & Soft Tissue}} {{c1::Osteomyelitis}} {{c1::Pneumonia}} {{c1::Infective Endocarditis}} {{c1::E…
Published	02/10/2024	Frequent sites of distant metastases associated with Staph. aureus {{c1::Bones and joints (especially when prosthetic materials are present)}} {{c1::E…
Published	02/10/2024	Investigations of Staph. aureus bacteraemias {{c1::Microscopy and Culture}} {{c1::Multiple blood cultures before commencing antibiotic therapy}} {{c1:…
Published	02/10/2024	Consider the use of {{c1::Transthoracic echocardiogram (TTE)}} for all patients with Staph. aureus bacteraemias while they are receiving IV therapy
Published	02/10/2024	If risk assessment is negative of SAB and patient is not penicillin allergic, treat as MSSA with {{c1::Flucloxacillin}}
Published	02/10/2024	Minimum duration of treatment for uncomplicated S. aureus bacteraemia is {{c1::14}} days using {{c1::Flucloxacillin}}
Published	02/10/2024	If patient is allergic to penicillin then use {{c1::vancomycin}} first line for MSSA and MRSA
Published	02/10/2024	If risk assessment is positive of SAB, treat as MRSA with {{c1::Vancomycin}}
Published	02/10/2024	Flucloxacillin is first-line for {{c1::MSSA::MSSA or MRSA}}
Published	02/10/2024	Vancomycin is first-line for {{c1::MRSA::MSSA or MRSA}}
Status	Last Update	Fields